• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Elligo Health Research and PatientLink partner

Elligo Health Research and PatientLink partner

November 14, 2017
CenterWatch Staff

Elligo Health Research, a clinical research infrastructure provider that brings together sponsors, physicians, patients and CROs to improve clinical trial access and efficiency, is now connecting physicians and patients to treatment options through a new partnership with PatientLink Enterprises, an innovative medical patient data collection and enrollment software development company.

To benefit its customers who are ready to bring clinical studies to their practice, PatientLink is recommending Elligo’s Goes Direct approach. The relationship connects physicians who are interested in research with the resources and infrastructure needed to make it possible.

“Introducing select clients to Elligo has allowed us to further fulfill our mission of connecting people to people—first patients to physicians with our electronic health record (EHR) solutions and now physicians to research with Elligo,” said Debi Willis, CEO and founder of PatientLink. “We are grateful to play a role in engaging physicians and patients in the research that will help uncover ways to live better and longer.”

“We are delighted to be advancing the care PatientLink’s physicians offer to their patients,” said Keith Fern, chief commercial officer at Elligo. “This opportunity will allow us to increase patient access to cutting edge clinical research by putting it in the hands of even more physicians. This is a win for everyone—for patients, for clinicians and for trial sponsors.”

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing